CeNeS sales and marketing update

CEN launched in the U.K. its Xefo non-steroidal anti-inflammatory drug (NSAID) to treat post-operative pain. CEN licensed the product from Nycomed Pharma A/S (Oslo, Norway) earlier this year (see Bio...